Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […]
/PRNewswire/ The global genome editing market size is estimated to grow by USD 7.23 billion from 2024-2028, according to Technavio. The market is estimated.
HC Wainwright reaffirmed their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report issued on Wednesday morning, Benzinga reports. They currently have a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at ($0.05) […]
HC Wainwright reissued their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at […]
Sangamo Therapeutics' (SGMO) "Buy" Rating Reiterated at HC Wainwright dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.